Sponsor or institution
Clinical trials and research at GE Healthcare
As of November 12, 2026, Find a Trial lists 15 clinical trials run by GE Healthcare that are recruiting, at sites in 13 countries (most in United States (6), Finland (5), Italy (2)). 2 were first registered in the last 30 days. By phase: Phase 2/3 (2), Phase 2 (1), Phase 4 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 2New in 30 days
- 13Countries
Newest trials
All recruiting trials (15)
-
Heart rate and respiration monitoring device: performance and usability in patients of all ages
We’re testing a new physiological monitor to see how well it works and how easy it is to use for patients from newborns to seniors.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Omni 128 cm PET/CT imaging system: comparing new scanner with standard PET/CT
This study tests a new Omni 128 cm PET/CT scanner by having adults with a planned clinical PET/CT also undergo an extra research scan to compare image quality.
-
Automated Non-Invasive Blood Pressure: Tracking Blood Pressure Changes Using SpO2 Data
This study tests an algorithm that estimates blood pressure changes using data from an SpO2 sensor in patients in the OR, PACU, or ICU who already have invasive BP measured as part of standard care.
-
SPECT/CT Performance Comparison Using StarGuide GX in Adults
This study tests whether the StarGuide GX SPECT/CT scan matches the results of a patient’s clinically indicated SPECT/CT in adults.
-
NIBP Accuracy Validation in Adults
This study tests how accurately a non-invasive blood pressure device measures blood pressure in adults by comparing it with arterial line readings.
-
New Non-Invasive Blood Pressure (NIBP) Enhancement for Neonates and Children
This study tests a new NIBP device enhancement in neonates and kids to see if it can measure blood pressure more accurately.
-
Next-generation spectral CT imaging data collection from clinical scans
This study tests how a new spectral CT system performs when used in real patient scans at St. Luke’s University Hospital Network to help with regulatory submissions.
-
Non-invasive blood pressure accuracy study for adults
This study tests whether non-invasive blood pressure readings match invasive aortic pressure measurements in adults who need arterial line monitoring.
-
Mangaciclanol for contrast-enhanced MRI to detect and characterize lesions in the brain and body in adults
This will test whether the contrast agent mangaciclanol helps MRI scans find and show suspected lesions in the brain or other body parts in adults compared with the standard agent gadobutrol.
-
NMT EasyFit Sensor and Cable usability and data collection
This study tests how well clinicians can use the NMT EasyFit Sensor with the NMT Cable to monitor neuromuscular block in adults during procedures requiring paralytic medications.
-
GEH300079 (68Ga) PET/CT scan to detect peritoneal carcinomatosis in colorectal, gastric, ovarian, and pancreatic cancers (PERISCOPE)
This will test whether a GEH300079 (68Ga) PET/CT scan can detect peritoneal carcinomatosis in adults with colorectal, gastric, ovarian, or pancreatic ductal adenocarcinoma who have known or suspected peritoneal disease.
-
Testing a new cardiac ultrasound system
This project will test a new cardiac ultrasound system in adults having intraoperative transesophageal echocardiography to see if it provides clear images and fits clinical workflow.
-
Evaluating Sonazoid for Liver Imaging in Children
This study is testing if a special contrast agent called Sonazoid can help doctors get better ultrasound images of liver problems in children to improve diagnosis.
-
Evaluating regadenoson for pediatric patients with heart conditions
This study is testing if regadenoson is safe for kids and infants with heart conditions who need a special heart test.
Quick answers
How many clinical trials run by GE Healthcare are recruiting right now?
15, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (6 trials), Finland (5 trials), Italy (2 trials), United Kingdom (2 trials), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 2: 1, Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.